Microfluidic technologies for circulating tumor cell isolation

Area of Science:

• Oncology
• Biotechnology
• Medical Diagnostics

Background:

• Metastasis, driven by circulating tumor cells (CTCs), is a primary cause of cancer mortality.
• Early detection and analysis of CTCs are essential for timely diagnosis, prognosis, and effective cancer treatment.
• Microfluidic technologies have emerged as powerful tools for CTC isolation and detection.

Purpose of the Study:

• To review current advanced microfluidic technologies for CTC isolation.
• To discuss the advantages and limitations of these methods for downstream assays.
• To explore single-cell isolation techniques and future microfluidic platform innovations.

Main Methods:

• Review of microfluidic technologies based on biological and physical principles.
• Analysis of methods for isolating individual CTCs, addressing genetic heterogeneity.
• Discussion of strategies to overcome current limitations in CTC isolation.

Main Results:

• Microfluidic technologies show significant potential for CTC isolation and detection.
• Various microfluidic approaches leverage different biological and physical properties.
• Single-cell isolation methods are advancing to address CTC heterogeneity.

Conclusions:

• Microfluidic technologies are vital for advancing CTC analysis in cancer diagnostics.
• Further innovation in microfluidic platforms is needed to overcome existing limitations.
• Improved CTC isolation and analysis promise better clinical outcomes for cancer patients.